EXCEDE® (Ceftiofur Crystalline Free Acid) Sterile Suspension Now Available In A 250 mL Bottle
MADISON, N.J. — Dec. 3, 2012 — EXCEDE® (ceftiofur crystalline free acid) Sterile Suspension is now available in a 250 mL vial. The larger bottle offers the same extended therapy and unquestionable assurance producers have come to count on to treat and control bovine respiratory disease (BRD) and foot rot in cattle.
“Producers across the country already know they can count on EXCEDE for extended therapy,” says Lee Bob Harper, DVM, associate director, Pfizer Animal Health, Cattle and Equine Technical Services. “Now, the larger bottle makes EXCEDE an even more convenient part of a BRD management solution for producers.”
EXCEDE is a top choice for beef producers, providing seven days of antimicrobial therapy for BRD and foot rot in a single dose. In addition to reducing the total number of treatments needed and helping to minimize labor and treatment costs, it is also effective against three of the major bacterial pathogens commonly associated with BRD — Mannheimia haemolytica, Pasteurella multocida and Histophilus somni — and two of the primary foot rot-causing bacteria, Fusobacterium necrophorum and Porphyromonas levii.
“The small dose volume of EXCEDE, at just 1.5 milliliters per hundredweight, means the product already offers more doses per bottle than most other leading antimicrobials,” Dr. Harper says. “With the EXCEDE 250 mL option, producers will be able to treat more cattle per bottle, meaning they can more efficiently treat cattle, save space on their medicine shelf and produce less waste.”
Important Safety Information: The use of EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Though safe in cattle when properly administered, inadvertent intra-arterial injection is possible and fatal. EXCEDE has a pre-slaughter withdrawal time of 13 days in cattle. Do not use in calves to be processed for veal.
About Pfizer Animal Health
Pfizer Animal Health, a business unit of Pfizer Inc., is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. For more than 60 years, we have been committed to enhancing the health of animals and bringing solutions to our customers who raise and care for them. To learn more, visit www.pfizeranimalhealth.com.
For more information, Contact:
Pfizer Animal Health
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States